Home About Our Services Experience Publications News & Events Contact Us Downloads
OUR SERVICES

Health Economics

Patient-Reported Outcomes

Market Access and Outcomes Strategy
> Consulting and Strategic Plans
> Payer and Pricing Research
> Reimbursement and Health Technology Assessment Submissions
> Product Value Dossiers
> Systematic and Structured Literature Reviews

Health Preference Assessment

Pharmacoepidemiology and Risk Management

Drug Safety and Pharmacovigilance

Biometrics

Clinical and Medical Services

 

RTI-HS HomeOur ServicesMarket Access and Outcomes Strategy › Consulting and Strategic Plans

Consulting and Strategic Plans

Our staff has deep methodological, project, and therapeutic experience. As consultants we provide valuable insights as you develop and commercialize your products. We offer flexible contracting arrangements to meet your needs, whether you require consultation on a specific project or wish to establish a long-term arrangement that will allow you to access to specific experts as needed.

We routinely assist our clients with the following:

Internal outcomes planning strategy
We develop outcomes research plans which include health economic and patient-reported outcomes activities required to generate robust evidence to help you differentiate your products, demonstrate their value, and gain successful market access.
Pricing, reimbursement, and market access strategy
We develop strategies based on market and product environment, payer requirements and treatment value that will support optimal pricing and subsequent successful market penetration for your product.
Value proposition and message creation
We create compelling value stories and strong evidence-based value messages which resonate with payers and effectively communicate the value of your product.
Competitive landscape and environmental scans
We provide recommendations for overcoming access challenges and maximizing opportunities for emerging products. Our comprehensive review includes a summary of current treatment standards, health technology assessments (HTAs), and pricing and reimbursement status.
HTA competitive grid analysis
We develop tools to help you understand the competitive landscape for particular therapeutic areas, based on quantitative ratings of the product attributes that will be important to payers.
Value communications planning
We design publication strategies to communicate the value of your product to key stakeholders.
Risk-sharing and patient access programs
We assess the feasibility and design of financially-based and performance-based, risk-sharing programs, as well as their impact on helping you gain market access.

 

Our Expertise

 


 
CONTACT US

 
Stephanie Barrows, MPH
Director, Market Access and Outcomes Strategy
Stephen M Beard, MSc
Vice President, Health Economics
Kati Copley-Merriman, MBA
Vice President, Market Access and Outcomes Strategy
Stephanie R Earnshaw, PhD
Vice President, US Health Economics
Anne Heyes, MBA
Head of Market Access and Outcomes Strategy, Europe
Melissa Juniper, MS
Senior Director, Market Access and Outcomes Strategy
Shahnaz Khan, MPH
Senior Director, Market Access and Outcomes Strategy
Deirdre Mladsi, BA
Head, Health Economics and Market Access
Margaret Mordin, MS
Senior Director, Market Access and Outcomes Strategy
Neil Roskell, MSc
Director, Evidence Review and HTA Analysis
Allan Scott, MHA
Director, Market Access and Outcomes Strategy
Beth H Sherrill, MS
Global Head, Biometrics
Sorrel Wolowacz, PhD
Director, Health Economics and HTA

US: +1.800.262.3011
Spain: +34.93.241.7766
UK: +44(0)161.232.3400
For a full list of scientific staff bios, click here.

 

Home | About | Our Services | Experience | Publications | News & Events | Contact Us | Downloads
©2008 RTI Health Solutions. All Rights Reserved.